Résultats de la recherche
10
Tout
Ferrellgas Partners, L.P. Reports Second Quarter Fiscal Year 2025 Results
07 mars 2025 08h30 HE
|
Ferrellgas Partners, L.P.
LIBERTY, Mo., March 07, 2025 (GLOBE NEWSWIRE) -- Ferrellgas Partners, L.P. (OTC: FGPR) (“Ferrellgas” or the “Company”) today reported financial results for its 2025 second fiscal quarter ended...
Innovative Food Holdings, Inc. Reports Financial Results for Fourth Quarter and Fiscal Year 2024
07 mars 2025 08h00 HE
|
Innovative Food Holdings
INNOVATIVE FOOD HOLDINGS, INC. REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2024
Advantage Solutions Reports Fourth Quarter and 2024 Results: Transformation Initiatives Continue to Strengthen the Company
07 mars 2025 07h00 HE
|
Advantage Solutions, Inc.
Advantage Solutions Reports Q4 and 2024 Results: Transformation Initiatives Continue to Strengthen the Company
Bimini Capital Management Announces Fourth Quarter 2024 Results
06 mars 2025 16h17 HE
|
Bimini Capital Management, INC
VERO BEACH, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- Bimini Capital Management, Inc. (OTCQB: BMNM), (“Bimini Capital,” “Bimini,” or the “Company”), today announced results of operations for the...
Full House Resorts Announces Fourth Quarter and Full-Year Results
06 mars 2025 16h05 HE
|
Full House Resorts, Inc.
- Quarterly and Annual Revenues Increased More Than 21% Compared to the Prior-Year Periods - American Place Casino Continued Its Expected Ramp-Up of Operations, With Revenues...
Serve Robotics Announces Fourth Quarter and Full Year 2024 Results
06 mars 2025 16h05 HE
|
Serve Robotics Inc.
Full year revenue of $1.8 million, an increase of 773% year-over-yearContinued geographic expansion in Los Angeles, successful launch in Miami, and planning entry into Dallas and Atlanta metrosReach...
Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025
06 mars 2025 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases with an...
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
06 mars 2025 08h00 HE
|
Phathom Pharmaceuticals
VOQUEZNA® (vonoprazan) generated $55.3 million in 2024 net revenues in its first full year of launch, driven by strong demand, including $29.7 million in Q4, an 81% increase from Q3Over 300,000 filled...
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025
06 mars 2025 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report its financial...
Currency Exchange International to Report its First Quarter 2025 Results on March 12, 2025, and Host Earnings Conference Call on March 13, 2025 at 8:30 AM EST
06 mars 2025 07h30 HE
|
Currency Exchange International
TORONTO, March 06, 2025 (GLOBE NEWSWIRE) -- Currency Exchange International, Corp. (the “Company”) (TSX: CXI; OTCBB: CURN), will report its financial results for the First Quarter of 2025 (ended...